FDA NDC Directory · JSON-LD · Markdown

oxybutynin

NDC 70771-1088 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA202332
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (15 mg/1)
Marketing started20170810
Package count6

External sources

Source: openFDA. Public-domain (CC0).